Precision prescribing of SGLT2-inhibitors in people with type 2 diabetes for primary prevention of heart failure: model development and validation study
Young KG., McGovern AP., Hopkins R., Jansz TT., Cardoso PM., Holman RR., Pearson ER., Hattersley AT., Jones AG., Docherty K., Sattar N., Shields BM., Dennis JM.